Curis, Inc. (CRIS) Reports First Quarter 2014 Financial Results
5/8/2014 9:29:09 AM
LEXINGTON, Mass., May 8, 2014 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused drug development company developing novel drug candidates for the treatment of human cancers, today reported its financial results for the first quarter ended March 31, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by